Classification of Neisseria meningitidis group B into distinct serotypes. 3. Application of a new bactericidal-inhibition technique to distribution of serotypes among cases and carriers.
D000818:Animals; D000942:Antigens, Bacterial / Q000032:analysis; D001431:Bacteriological Techniques; D001770:Blood Bactericidal Activity; D002353:Carrier State / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D008297:Male; D008589:Meningococcal Infections / Q000382:microbiology*; D008722:Methods; D009326:Naval Medicine; D009345:Neisseria meningitidis / Q000145:classification* / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification; D011233:Precipitin Tests; D011817:Rabbits / Q000276:immunology; D012703:Serotyping; D013444:Sulfisoxazole / Q000494:pharmacology
D000942:Antigens, Bacterial; D007106:Immune Sera; D013444:Sulfisoxazole